Remove 2030 Remove Pharma Companies Remove Regulations
article thumbnail

Pharma Contract Sales Outlook 2025–2030: Multilingual Teams Drive Global Expansion

The Pharma Data

Billion by 2030: Strategic Insights, Regional Trends, and Technological Shifts Reshaping the Landscape The global pharmaceutical contract sales outsourcing (CSO) market is entering a transformative phase, with its value expected to grow from $17.3 billion by 2030 , reflecting a compound annual growth rate (CAGR) of 6.2%.

article thumbnail

Why Do Pharma Companies Outsource to CROs?

Vial

over the forecast period (2022-2030). Role of CROs CROs are third-party organizations that offer support and resources to pharmaceutical, biotech, and medical device companies, as well as research institutions, universities, and government organizations—the so-called sponsors—for their research.